Basiliximab (Simulect (R)) for the treatment of steroid-resistant graft-versus-host-disease (GvHD) after nonmyeldablative allogeneic hematopoietic stem cell transplantation (HSCT).
Academic Article
Publication Date:
2002
Iris type:
1.1 Articolo in rivista
List of contributors:
Ciceri, Fabio; Bernardi, M; Peccatori, J; Montefusco, V; Guggiari, E; Callegaro, L; Corti, C; Pescarollo, A; Corradini, P; Bregni, M.
Published in: